Mouse Axl/AI323647/Ark ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_009465.4)

Cat. No.: vGMAAV001308

Pre-made Mouse Axl/AI323647/Ark Adeno-associated virus particle for Axl in-vivo study, mechanism of action (MOA) research and Axl-associated gene therapy development.

At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name AAV serotype AAV Grade AAV quantity
vGMAAV001308 Mouse Axl Adeno-associate virus(AAV) particle AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF Pilot Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
Research Grade 1.0E+12VG/ml
5.0E+12VG/ml
1E+13VG/ml
5E+13VG/ml
1E+14VG/ml
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAAV001308
Gene Name Axl
Accession Number NM_009465.4
Gene ID 26362
Species Mouse
Product Type Adeno-associate virus(AAV) particle (overexpression)
Insert Length 2667 bp
Gene Alias AI323647,Ark,Tyro7,Ufo
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 6xHis (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGGCAGGGTCCCGCTGGCCTGGTGGTTGGCGCTGTGCTGCTGGGGGTGTGCAGCCCATAAGGACACACAGACCGAGGCTGGCAGCCCGTTTGTGGGGAACCCAGGGAATATCACAGGTGCCAGAGGACTCACGGGGACACTTCGGTGTGAGCTCCAGGTTCAGGGGGAACCCCCTGAGGTGGTGTGGCTTCGAGATGGACAGATCCTAGAACTGGCTGATAACACCCAGACCCAGGTGCCTCTGGGCGAAGACTGGCAAGATGAATGGAAAGTTGTCAGTCAGCTCAGAATCTCAGCCCTGCAACTTTCAGATGCAGGGGAGTACCAGTGTATGGTGCATCTAGAAGGACGGACCTTTGTGTCTCAGCCGGGCTTTGTAGGGCTGGAAGGTCTCCCGTACTTCCTGGAGGAGCCTGAGGACAAAGCTGTGCCTGCCAACACCCCTTTCAACCTAAGCTGCCAGGCCCAGGGACCCCCGGAACCCGTGACCCTACTCTGGCTTCAAGATGCTGTCCCCCTGGCCCCAGTCACAGGACACAGCTCCCAGCACAGTCTGCAAACTCCAGGCCTGAACAAGACATCTTCTTTCTCATGTGAAGCCCACAATGCCAAGGGAGTCACCACCTCCCGCACAGCCACCATCACAGTGCTCCCCCAGAGGCCTCACCATCTCCACGTGGTTTCCAGACAACCTACGGAGCTAGAGGTAGCTTGGACCCCTGGCCTGAGTGGCATCTACCCGCTCACCCACTGCAACCTGCAGGCCGTGCTGTCAGACGATGGGGTGGGTATCTGGCTGGGAAAGTCAGATCCTCCTGAAGACCCCCTCACCTTGCAAGTATCAGTGCCCCCCCACCAGCTTCGGCTGGAAAAGCTCCTTCCTCACACCCCGTATCACATCCGGATATCCTGCAGCAGCAGCCAGGGCCCCTCACCTTGGACCCACTGGCTTCCTGTGGAGACCACAGAGGGAGTGCCCTTGGGTCCCCCTGAGAACGTTAGCGCCATGCGGAATGGGAGCCAGGTCCTCGTGCGTTGGCAGGAGCCAAGGGTGCCCCTGCAAGGCACCCTGTTAGGGTACCGGCTGGCATATCGAGGCCAGGACACCCCCGAGGTACTTATGGATATAGGGCTAACTCGAGAGGTGACCTTGGAACTGCGGGGGGACAGGCCTGTGGCTAACCTGACTGTGTCTGTGACAGCCTATACCTCGGCTGGGGATGGGCCCTGGAGCCTTCCTGTGCCCCTAGAGCCCTGGCGCCCAGGGCAAGGACAGCCACTCCACCATCTGGTGAGTGAACCCCCACCTCGCGCCTTCTCGTGGCCTTGGTGGTATGTACTGCTGGGAGCACTTGTGGCTGCCGCCTGCGTCCTCATCTTGGCCCTGTTCCTTGTCCATCGGAGGAAGAAGGAGACTCGATATGGGGAGGTGTTTGAGCCAACCGTGGAAAGAGGTGAACTGGTAGTCAGGTACCGTGTCCGAAAGTCCTACAGCCGGCGGACCACTGAAGCCACCTTGAACAGTCTGGGCATCAGTGAAGAGCTGAAGGAGAAACTACGAGACGTCATGGTAGATCGGCATAAGGTGGCCTTGGGGAAGACCCTGGGAGAAGGAGAATTTGGCGCTGTGATGGAAGGTCAGCTCAATCAGGATGACTCCATCCTCAAGGTCGCTGTGAAGACCATGAAAATTGCCATCTGCACAAGATCAGAGCTGGAGGATTTCCTGAGTGAAGCTGTCTGCATGAAGGAATTTGACCACCCCAACGTCATGAGGCTCATTGGCGTCTGTTTTCAGGGCTCTGACAGAGAGGGTTTCCCAGAACCTGTGGTCATCTTGCCTTTCATGAAACACGGAGACCTACACAGTTTCCTCCTGTACTCCCGGCTCGGGGACCAGCCAGTGTTCCTGCCCACTCAGATGCTAGTGAAGTTCATGGCCGACATTGCCAGTGGTATGGAGTACCTGAGTACCAAGAGATTCATACATCGGGACCTGGCTGCCAGGAACTGCATGCTGAATGAGAACATGTCCGTGTGTGTGGCAGACTTCGGGCTCTCCAAGAAGATCTACAACGGGGATTACTACCGCCAAGGGCGCATTGCCAAGATGCCAGTCAAGTGGATTGCTATTGAGAGTCTGGCAGATCGGGTCTACACCAGCAAGAGCGATGTGTGGTCCTTCGGTGTGACAATGTGGGAGATCGCCACCCGAGGCCAAACTCCCTATCCAGGGGTGGAGAACAGTGAGATTTACGACTACCTGCGTCAAGGAAATCGGCTGAAACAGCCTGTGGACTGTCTGGACGGCCTGTATGCCCTGATGTCTCGGTGCTGGGAACTGAACCCTCGAGACCGGCCAAGTTTTGCGGAGCTCCGGGAAGACTTGGAGAACACACTGAAGGCTCTGCCCCCTGCTCAGGAGCCAGATGAAATCCTCTATGTCAACATGGATGAGGGCGGAAGCCACCTTGAACCCCGTGGGGCTGCTGGAGGAGCTGACCCCCCAACCCAACCTGATCCTAAGGATTCCTGTAGCTGTCTCACTGCAGCTGACGTCCACTCAGCTGGACGCTATGTCCTTTGTCCTTCTACAGCCCCAGGACCCACTCTGTCTGCTGACAGAGGCTGCCCAGCACCTCCAGGGCAGGAGGACGGAGCCTGA
ORF Protein Sequence MGRVPLAWWLALCCWGCAAHKDTQTEAGSPFVGNPGNITGARGLTGTLRCELQVQGEPPEVVWLRDGQILELADNTQTQVPLGEDWQDEWKVVSQLRISALQLSDAGEYQCMVHLEGRTFVSQPGFVGLEGLPYFLEEPEDKAVPANTPFNLSCQAQGPPEPVTLLWLQDAVPLAPVTGHSSQHSLQTPGLNKTSSFSCEAHNAKGVTTSRTATITVLPQRPHHLHVVSRQPTELEVAWTPGLSGIYPLTHCNLQAVLSDDGVGIWLGKSDPPEDPLTLQVSVPPHQLRLEKLLPHTPYHIRISCSSSQGPSPWTHWLPVETTEGVPLGPPENVSAMRNGSQVLVRWQEPRVPLQGTLLGYRLAYRGQDTPEVLMDIGLTREVTLELRGDRPVANLTVSVTAYTSAGDGPWSLPVPLEPWRPGQGQPLHHLVSEPPPRAFSWPWWYVLLGALVAAACVLILALFLVHRRKKETRYGEVFEPTVERGELVVRYRVRKSYSRRTTEATLNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQGSDREGFPEPVVILPFMKHGDLHSFLLYSRLGDQPVFLPTQMLVKFMADIASGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPVDCLDGLYALMSRCWELNPRDRPSFAELREDLENTLKALPPAQEPDEILYVNMDEGGSHLEPRGAAGGADPPTQPDPKDSCSCLTAADVHSAGRYVLCPSTAPGPTLSADRGCPAPPGQEDGA

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMAAV001308 Mouse Axl Adeno-associate virus(AAV) plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.